SEC Form 4 · accession 0000874716-26-000127
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence D Kingsley
Director
Period of report
Sep 4, 2026
Accepted (ET)
Sep 9, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 4, 2026 | M | 2,203 | $114.17 | A | 11,771 | D | |
| Common StockF1 | Sep 4, 2026 | S | 2,203 | $532.0826 | D | 9,568 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy)F3,F2 | $114.17 | Sep 4, 2026 | M | 2,203 | D | — | Nov 30, 2026 | Common Stock | 2,203 | 0 | D |
Explanation of responses
- F1Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2017.
- F3Not applicable.